Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement

High Deep-Remission Rate With Triple Regimen for Relapsed/Refractory CLL

Time-limited treatment with a three-drug combination for relapsed/refractory chronic lymphocytic leukemia (CLL) produced long-term undetectable residual disease in more than 90% of patients, updated results

April 25, 2024

AATec Medical Announces Creation of Scientific Advisory Board – Biotech Investments

EQS-News: AATec Medical GmbH / Key word(s): Miscellaneous AATec Medical GmbH: AATec Medical Announces Creation of Scientific Advisory Board 10.10.2023 / 11:00 CET/CEST The issuer

October 11, 2023

WHO experts recommend the use of Takeda’s dengue vaccine QDENGA

Takeda today announced that the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization shared recommendations for use of QDENGA® (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003).

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.